Mortimer J. Buckley
Mortimer J. Buckley's purchase track record
Mortimer J. Buckley has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/5/2026 | PFE | $960K | pending | pending | — |
| 3/3/2026 | BA | $500K | -2.9% | -8.2% | +11.9% |
| 8/19/2025 | BA | $497K | -15.7% | +8.5% | +6.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Boeing (BA) Nears FAA Approval for 737 MAX 10 Amid New Jet Talks. The Federal Aviation Administration is close to approving the Boeing 737 MAX 10, which could expand the company's commercial jet lineup. At the same time, Boeing is in discussions to supply up to 50 additional wide‑body aircraft, indicating ongoing demand for its larger planes. Analysts note that a recent price‑target reduction by RBC reflects lingering uncertainty over defense spending, adding a mixed backdrop for the stock.
Transaction History
| PFE | ▲ Buy | Open Market | 37,632 | $960K | 8/5/2026 | View on chart |
| BA | ▲ Buy | Open Market | 2,230 | $500K | 3/3/2026 | View on chart |
| BA | ▲ Buy | Open Market | 2,200 | $497K | 8/19/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Pfizer Declares 352nd Straight Dividend, Holds Steady Amid Vaccine Selloff
Pfizer announced its 352nd consecutive quarterly dividend, keeping a yield of about 5.4%. The company’s share price has stayed flat even as other vaccine makers like Novavax and Moderna fell. A new approval for the drug Tukysa could alter the company’s outlook, and analysts are watching the upcoming Q3 2026 earnings report for more detail.
Pfizer Declares 352nd Straight Dividend, Holds Steady Amid Vaccine Selloff. Pfizer announced its 352nd consecutive quarterly dividend, keeping a yield of about 5.4%. The company’s share price has stayed flat even as other vaccine makers like Novavax and Moderna fell. A new approval for the drug Tukysa could alter the company’s outlook, and analysts are watching the upcoming Q3 2026 earnings report for more detail.